“…The utility of combining tests or performing risk stratification in a sequential manner has been demonstrated , 22,23 Based on the findings of the Risk Estimation Following Infarction, Noninvasive Evaluation (REFINE) study, 24 the REFINE-ICD trial is evaluating the efficacy of the ICD to reduce mortality in postinfarction patients with ejection fraction of 36% to 49% and abnormal T wave alternans and heart rate turbulence. The ideal combination of parameters, as well as time(s) for evaluation, need to be determined.…”